Does Timing of Cytoreductive Nephrectomy Impact Patient Survival With Metastatic Renal Cell Carcinoma in the Tyrosine Kinase Inhibitor Era? A Multi-institutional Study REPLY

被引：0
|
作者：
Derweesh, Ithaar H. [1 ]
Stroup, Sean P. [1 ]
Millard, Frederick [2 ]
机构：
[1] Univ Calif San Diego, Sch Med, Dept Surg, Div Urol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Internal Med, Div Med Oncol, La Jolla, CA 92093 USA
来源：
UROLOGY | 2013年 / 81卷 / 04期
关键词：
D O I：
10.1016/j.urology.2012.10.058
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：812 / 812
页数：1
相关论文
共 50 条
  • [41] Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy
    Buchler, Tomas
    Poprach, Alexandr
    TARGETED ONCOLOGY, 2024, 19 (02) : 175 - 180
  • [42] PROGNOSTIC IMPACT OF KINETICS OF C-REACTIVE PROTEIN BETWEEN BEFORE AND AFTER SURGERY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY TREATED WITH TYROSINE KINASE INHIBITOR
    Teishima, Jun
    Ohara, Shinya
    Hieda, Keisuke
    Shinmei, Shunsuke
    Inoue, Shogo
    Hayashi, Tetsutaro
    Mochizuki, Hideki
    Mita, Koji
    Matsubara, Akio
    JOURNAL OF UROLOGY, 2018, 199 (04): : E872 - E873
  • [43] Improved survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in the contemporary immunotherapy era: An analysis of the National Cancer Database
    Singla, Nirmish
    Hutchinson, Ryan C.
    Ghandour, Rashed A.
    Freifeld, Yuval
    Fang, Dong
    Sagalowsky, Arthur I.
    Lotan, Yair
    Bagrodia, Aditya
    Margulis, Vitaly
    Hammers, Hans J.
    Woldu, Solomon L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (06) : 604.e9 - 604.e17
  • [44] Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
    Meagher, Margaret F.
    Minervini, Andrea
    Mir, Maria C.
    Cerrato, Clara
    Rebez, Giacomo
    Autorino, Riccardo
    Hampton, Lance
    Campi, Riccardo
    Kriegmair, Maximilian
    Linares, Estefania
    Hevia, Vital
    Musquera, Maria
    D'Anna, Mauricio
    Roussel, Eduard
    Albersen, Maarten
    Pavan, Nicola
    Claps, Francesco
    Antonelli, Alessandro
    Marchioni, Michele
    Paksoy, Nail
    Erdem, Selcuk
    Derweesh, Ithaar H.
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 63 : 71 - 80
  • [45] Impact of renal cell carcinoma histological variants on recurrence after partial nephrectomy: A multi-institutional, prospective study (UROCCR study 82)
    Tabourin, T.
    Pinar, U.
    Parra, J.
    Vaessen, C.
    Bensalah, C-K
    Audenet, F.
    Bigot, P.
    Champy, C.
    Olivier, J.
    Bruyere, F.
    Nicolas, D.
    Paparel, P.
    Parier, B.
    Durand, X.
    Lang, H.
    Branger, N.
    Long, J-A
    Durand, M.
    Waeckel, T.
    Charles, T.
    Cussenot, O.
    Xylinas, E.
    Bernhard, J-C
    Roupret, M.
    EUROPEAN UROLOGY, 2022, 81 : S217 - S218
  • [46] RADICAL NEPHRECTOMY WITH OR WITHOUT LYMPH NODE DISSECTION FOR NON-METASTATIC RENAL CELL CARCINOMA: A MULTI-INSTITUTIONAL ANALYSIS
    Gershman, Boris
    Thompson, Houston
    Boorjian, Stephen
    Larcher, Alessandro
    Capitanio, Umberto
    Montorsi, Francesco
    Carenzi, Cristina
    Bertini, Roberto
    Briganti, Alberto
    Lohse, Christine
    Cheville, John
    Leibovich, Bradley
    JOURNAL OF UROLOGY, 2017, 197 (04): : E737 - E737
  • [47] Multi-Institutional Analysis of Localized Renal Cell Carcinoma that Demonstrates the Impact of Diabetic Status on Prognosis After Nephrectomy
    Yun-Sok Ha
    Won Tae Kim
    Seok-Joong Yun
    Sang-Cheol Lee
    Wun-Jae Kim
    Yong Hyun Park
    Seok Ho Kang
    Sung-Hoo Hong
    Seok-Soo Byun
    Yong-June Kim
    Annals of Surgical Oncology, 2013, 20 : 3662 - 3668
  • [48] Multi-Institutional Analysis of Localized Renal Cell Carcinoma that Demonstrates the Impact of Diabetic Status on Prognosis After Nephrectomy
    Ha, Yun-Sok
    Kim, Won Tae
    Yun, Seok-Joong
    Lee, Sang-Cheol
    Kim, Wun-Jae
    Park, Yong Hyun
    Kang, Seok Ho
    Hong, Sung-Hoo
    Byun, Seok-Soo
    Kim, Yong-June
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (11) : 3662 - 3668
  • [49] CLINICAL OUTCOMES IN PATIENTS WITH METASTATIC PAPILLARY RENAL CELL CARCINOMA: A JAPANESE MULTI-INSTITUTIONAL STUDY
    Ito, Keiichi
    Mikami, Shuji
    Tatsugami, Katsunori
    Masumori, Naoya
    Shinohara, Nobuo
    Kondo, Tsunenori
    Nakanishi, Shotaro
    Nagashima, Yoji
    Eto, Masatoshi
    Kamba, Tomomi
    Kuroda, Naoto
    Tomita, Yoshihiko
    Matsuyama, Hideyasu
    Onishi, Tetsuro
    Tsushima, Tomoyasu
    Nakazawa, Hayakazu
    Oya, Mototsugu
    Ozono, Seiichiro
    Naito, Seiji
    Asano, Tomohiko
    JOURNAL OF UROLOGY, 2016, 195 (04): : E23 - E24
  • [50] Early Tumor Shrinkage Under Treatment with First-line Tyrosine Kinase Inhibitors as a Predictor of Overall Survival in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Multi-Institutional Study in Japan
    Miyake, Hideaki
    Miyazaki, Akira
    Imai, Satoshi
    Harada, Ken-ichi
    Fujisawa, Masato
    TARGETED ONCOLOGY, 2016, 11 (02) : 175 - 182
12345